204 related articles for article (PubMed ID: 2277223)
1. [Combined treatment in patients with carcinoma in situ of the urinary bladder using intravesical pirarubicin, irradiation and hyperthermia].
Takechi T; Kawamura M; Nakagawa H; Inatsuki S; Akiyama K; Yano M; Sumiyoshi Y; Mandai K; Moriwaki S; Kataoka M
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2724-7. PubMed ID: 2277223
[TBL] [Abstract][Full Text] [Related]
2. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
3. [Application of radiofrequency hyperthermia for treating advanced urinary bladder cancer--a case report].
Kubota Y; Takebayashi S; Asakura K; Oshima H
Gan No Rinsho; 1984 Feb; 30(2):215-9. PubMed ID: 6200623
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
Lamm DL; Blumenstein BA; Crawford ED; Montie JE; Scardino P; Grossman HB; Stanisic TH; Smith JA; Sullivan J; Sarosdy MF
N Engl J Med; 1991 Oct; 325(17):1205-9. PubMed ID: 1922207
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer.
Colombo R; Da Pozzo LF; Lev A; Freschi M; Gallus G; Rigatti P
J Urol; 1996 Apr; 155(4):1227-32. PubMed ID: 8632537
[TBL] [Abstract][Full Text] [Related]
6. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
[TBL] [Abstract][Full Text] [Related]
7. [The study on intravesical instillation of THP in the treatment of in-situ and superficial bladder cancers].
Aota Y; Okamoto N; Morikawa S; Yoshida K
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1015-8. PubMed ID: 1626937
[TBL] [Abstract][Full Text] [Related]
8. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical data in bladder cancer immunotherapy with Connaught BCG (ImmuCyst).
Barreto L; Csizer Z; Sparkes JD
Dev Biol Stand; 1992; 77():229-31. PubMed ID: 1426667
[TBL] [Abstract][Full Text] [Related]
10. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Soloway MS; Jordan AM; Murphy WM
Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
[TBL] [Abstract][Full Text] [Related]
11. Cystectomy: the treatment of choice in patients with carcinoma in situ of the urinary bladder?
Jakse G; Putz A; Feichtinger J
Eur J Surg Oncol; 1989 Jun; 15(3):211-6. PubMed ID: 2737308
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
[TBL] [Abstract][Full Text] [Related]
13. [A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer].
Kawamura J; Tochigi H; Obata K; Ueda K; Otaguro K; Kuriyama M; Shinoda M; Naruse K; Murase T; Hasegawa Y
Hinyokika Kiyo; 1992 Mar; 38(3):379-85. PubMed ID: 1523998
[TBL] [Abstract][Full Text] [Related]
14. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
Deng JH; Bai JL; Zhang SS; Ma PC; Wan JH
Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
[TBL] [Abstract][Full Text] [Related]
15. Bacillus Calmette-Guérin immunotherapy. Techniques and results.
Brosman SA
Urol Clin North Am; 1992 Aug; 19(3):557-64. PubMed ID: 1636239
[TBL] [Abstract][Full Text] [Related]
16. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma.
Colombo R; Da Pozzo LF; Salonia A; Rigatti P; Leib Z; Baniel J; Caldarera E; Pavone-Macaluso M
J Clin Oncol; 2003 Dec; 21(23):4270-6. PubMed ID: 14581436
[TBL] [Abstract][Full Text] [Related]
17. [Clinical investigation on intravesical instillation of high-dose pirarubicin during perioperative period to prevent bladder carcinoma recurrence].
Gao JG; Tian T; Song YL; Dong ZY; Yang XF
Zhonghua Wai Ke Za Zhi; 2010 Nov; 48(21):1650-2. PubMed ID: 21211262
[TBL] [Abstract][Full Text] [Related]
18. Treatment of superficial carcinoma of the bladder.
Paulson DF
Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
[No Abstract] [Full Text] [Related]
19. [A case of anaphylactic shock induced by pirarubicin hydrochloride].
Mitsuhashi M; Iwata H; Kiyota A; Kamizuru M; Nakatani T
Hinyokika Kiyo; 2004 Apr; 50(4):257-9. PubMed ID: 15188619
[TBL] [Abstract][Full Text] [Related]
20. Treatment of bladder cancer with intravesical instillation of adriamycin.
Pavone-Macaluso M; Ingargiola GB; Tripi M; Lamartina M
Prog Clin Biol Res; 1984; 162B():181-91. PubMed ID: 6390445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]